|
Segment Information (Tables)
|
9 Months Ended |
|
Jun. 30, 2013
|
| Notes to Financial Statements [Abstract] |
|
| Revenues and EBT for reportable segments |
The table below presents revenues and EBT for reportable segments (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QCT |
|
QTL |
|
QWI |
|
QSI |
|
Reconciling
Items
|
|
Total |
For the three months ended: |
|
|
|
|
|
|
|
|
|
|
|
June 30, 2013 |
|
|
|
|
|
|
|
|
|
|
|
Revenues |
$ |
4,222 |
|
|
$ |
1,867 |
|
|
$ |
158 |
|
|
$ |
— |
|
|
$ |
(4 |
) |
|
$ |
6,243 |
|
EBT |
738 |
|
|
1,633 |
|
|
(16 |
) |
|
51 |
|
|
(496 |
) |
|
1,910 |
|
June 24, 2012 |
|
|
|
|
|
|
|
|
|
|
|
Revenues |
$ |
2,869 |
|
|
$ |
1,593 |
|
|
$ |
160 |
|
|
$ |
— |
|
|
$ |
4 |
|
|
$ |
4,626 |
|
EBT |
472 |
|
|
1,407 |
|
|
(6 |
) |
|
(16 |
) |
|
(276 |
) |
|
1,581 |
|
|
|
|
|
|
|
|
|
|
|
|
|
For the nine months ended: |
|
|
|
|
|
|
|
|
|
|
|
June 30, 2013 |
|
|
|
|
|
|
|
|
|
|
|
Revenues |
$ |
12,258 |
|
|
$ |
5,680 |
|
|
$ |
459 |
|
|
$ |
— |
|
|
$ |
(12 |
) |
|
$ |
18,385 |
|
EBT |
2,487 |
|
|
4,968 |
|
|
(20 |
) |
|
66 |
|
|
(1,129 |
) |
|
6,372 |
|
June 24, 2012 |
|
|
|
|
|
|
|
|
|
|
|
Revenues |
$ |
9,012 |
|
|
$ |
4,755 |
|
|
$ |
471 |
|
|
$ |
— |
|
|
$ |
13 |
|
|
$ |
14,251 |
|
EBT |
1,810 |
|
|
4,215 |
|
|
(15 |
) |
|
(149 |
) |
|
(824 |
) |
|
5,037 |
|
|
| Reconciling items for reportable segments - revenues |
Reconciling items in the previous table were as follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Nine Months Ended |
|
June 30,
2013 |
|
June 24,
2012 |
|
June 30,
2013 |
|
June 24,
2012 |
Revenues |
|
|
|
|
|
|
|
Nonreportable segments |
$ |
(2 |
) |
|
$ |
5 |
|
|
$ |
(8 |
) |
|
$ |
16 |
|
Intersegment eliminations |
(2 |
) |
|
(1 |
) |
|
(4 |
) |
|
(3 |
) |
|
$ |
(4 |
) |
|
$ |
4 |
|
|
$ |
(12 |
) |
|
$ |
13 |
|
EBT |
|
|
|
|
|
|
|
Unallocated cost of equipment and services revenues |
$ |
(82 |
) |
|
$ |
(73 |
) |
|
$ |
(258 |
) |
|
$ |
(211 |
) |
Unallocated research and development expenses |
(201 |
) |
|
(181 |
) |
|
(591 |
) |
|
(519 |
) |
Unallocated selling, general and administrative expenses |
(112 |
) |
|
(114 |
) |
|
(376 |
) |
|
(397 |
) |
Unallocated investment income, net |
176 |
|
|
204 |
|
|
644 |
|
|
622 |
|
Nonreportable segments |
(277 |
) |
|
(112 |
) |
|
(548 |
) |
|
(319 |
) |
|
$ |
(496 |
) |
|
$ |
(276 |
) |
|
$ |
(1,129 |
) |
|
$ |
(824 |
) |
QCT revenues for the three and nine months ended on both June 30, 2013 and June 24, 2012 included $1 million and $3 million of intersegment revenues, respectively. All other revenues for reportable segments were from external customers for all periods presented.
|
| Reconciling items for reportable segments - EBT |
Reconciling items in the previous table were as follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Nine Months Ended |
|
June 30,
2013 |
|
June 24,
2012 |
|
June 30,
2013 |
|
June 24,
2012 |
Revenues |
|
|
|
|
|
|
|
Nonreportable segments |
$ |
(2 |
) |
|
$ |
5 |
|
|
$ |
(8 |
) |
|
$ |
16 |
|
Intersegment eliminations |
(2 |
) |
|
(1 |
) |
|
(4 |
) |
|
(3 |
) |
|
$ |
(4 |
) |
|
$ |
4 |
|
|
$ |
(12 |
) |
|
$ |
13 |
|
EBT |
|
|
|
|
|
|
|
Unallocated cost of equipment and services revenues |
$ |
(82 |
) |
|
$ |
(73 |
) |
|
$ |
(258 |
) |
|
$ |
(211 |
) |
Unallocated research and development expenses |
(201 |
) |
|
(181 |
) |
|
(591 |
) |
|
(519 |
) |
Unallocated selling, general and administrative expenses |
(112 |
) |
|
(114 |
) |
|
(376 |
) |
|
(397 |
) |
Unallocated investment income, net |
176 |
|
|
204 |
|
|
644 |
|
|
622 |
|
Nonreportable segments |
(277 |
) |
|
(112 |
) |
|
(548 |
) |
|
(319 |
) |
|
$ |
(496 |
) |
|
$ |
(276 |
) |
|
$ |
(1,129 |
) |
|
$ |
(824 |
) |
QCT revenues for the three and nine months ended on both June 30, 2013 and June 24, 2012 included $1 million and $3 million of intersegment revenues, respectively. All other revenues for reportable segments were from external customers for all periods presented.
Amounts included in unallocated expenses related to the amortization and impairment of certain intangible assets, contract terminations and the recognition of the step-up of inventories to fair value that resulted from acquisitions were as follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Nine Months Ended |
|
June 30,
2013 |
|
June 24,
2012 |
|
June 30,
2013 |
|
June 24,
2012 |
Unallocated cost of equipment and services revenues |
$ |
64 |
|
|
$ |
54 |
|
|
$ |
203 |
|
|
$ |
156 |
|
Unallocated research and development expenses |
1 |
|
|
— |
|
|
2 |
|
|
— |
|
Unallocated selling, general and administrative expenses |
6 |
|
|
7 |
|
|
20 |
|
|
21 |
|
|
| Segment assets and reconciling items |
Segment assets and reconciling items were as follows (in millions):
|
|
|
|
|
|
|
|
|
|
June 30,
2013 |
|
September 30,
2012 |
QCT |
$ |
3,441 |
|
|
$ |
2,278 |
|
QTL |
40 |
|
|
63 |
|
QWI |
126 |
|
|
129 |
|
QSI |
540 |
|
|
1,424 |
|
Reconciling items |
42,662 |
|
|
39,118 |
|
Total consolidated assets |
$ |
46,809 |
|
|
$ |
43,012 |
|
|